Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CLBT 
Cellebrite DI (CLBT)
Top performer
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/23/2025: CLBT (4-star) is a STRONG-BUY. BUY since 44 days. Simulated Profits (14.34%). Updated daily EoD!
Upturn Star Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $23.57
1 Year Target Price $23.57
| 6 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 188.33% | Avg. Invested days 80 | Today’s Advisory Regular Buy |
Upturn Star Rating | Upturn Advisory Performance  5.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 10/23/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.35B USD | Price to earnings Ratio - | 1Y Target Price 23.57 |
Price to earnings Ratio - | 1Y Target Price 23.57 | ||
Volume (30-day avg) 8 | Beta 1.29 | 52 Weeks Range 13.10 - 26.30 | Updated Date 10/23/2025 |
52 Weeks Range 13.10 - 26.30 | Updated Date 10/23/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.72 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -34.56% | Operating Margin (TTM) 14.58% |
Management Effectiveness
Return on Assets (TTM) 5.95% | Return on Equity (TTM) -81.98% |
Valuation
Trailing PE - | Forward PE 37.17 | Enterprise Value 4137609774 | Price to Sales(TTM) 9.95 |
Enterprise Value 4137609774 | Price to Sales(TTM) 9.95 | ||
Enterprise Value to Revenue 9.47 | Enterprise Value to EBITDA 93.78 | Shares Outstanding 244469106 | Shares Floating 112431342 |
Shares Outstanding 244469106 | Shares Floating 112431342 | ||
Percent Insiders 42.59 | Percent Institutions 49.75 |
Upturn AI SWOT
Cellebrite DI
Company Overview
History and Background
Cellebrite DI was founded in 1999 and pioneered mobile data extraction technology. Initially focused on data transfer between mobile phones, it evolved into a leader in digital intelligence solutions for law enforcement, government, and enterprise organizations.
Core Business Areas
- Digital Intelligence Solutions: Offers solutions for collecting, reviewing, analyzing, and managing digital evidence from mobile devices, computers, and cloud sources.
- Data Extraction and Decoding: Provides technology to access and decode data from a wide range of devices, including locked or damaged phones.
- Analytics and Investigation Management: Offers tools to analyze extracted data, identify patterns, and manage investigations efficiently.
- Training and Support: Provides training and support services to ensure users can effectively utilize Cellebrite's solutions.
Leadership and Structure
Cellebrite DI is led by a Chief Executive Officer (CEO) and has a structured organizational hierarchy including departments for sales, marketing, R&D, and customer support.
Top Products and Market Share
Key Offerings
- UFED (Universal Forensic Extraction Device): Cellebrite's flagship product for extracting data from mobile devices. Cellebrite holds a significant market share, estimated to be between 40-50% of the digital intelligence market for mobile devices. Competitors include Magnet Forensics, MSAB, and Oxygen Forensics. Revenue from UFED is estimated to contribute 60-70% of total revenue.
- Cellebrite Premium: A solution that bypasses security measures on locked iOS and Android devices. Market share data is not publicly available. Competitors include GrayKey from Grayshift and other similar device unlocking services. Revenue generated by Cellebrite Premium is estimated to contribute around 20-25% of total revenue.
- Cellebrite Pathfinder: An analytics platform that helps investigators analyze and visualize digital evidence. Market share data is not publicly available. Competitors include IBM i2 Analyst's Notebook and Palantir. Revenue contribution is estimated to be 10-15% of total revenue.
Market Dynamics
Industry Overview
The digital intelligence industry is growing rapidly due to the increasing volume of digital evidence in investigations. The market is driven by the need for efficient and effective tools for data extraction, analysis, and management.
Positioning
Cellebrite DI is a leader in the digital intelligence market, known for its advanced technology, broad device support, and strong brand recognition. It has a competitive advantage in its long history and established customer base.
Total Addressable Market (TAM)
The TAM for the digital intelligence market is estimated to be $5 billion to $10 billion. Cellebrite DI is well-positioned to capture a significant portion of this market, focusing on government, law enforcement, and enterprise customers.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Advanced technology
- Extensive device support
- Established customer base
- Comprehensive digital intelligence platform
Weaknesses
- High price point
- Dependency on government contracts
- Ethical concerns related to privacy
- Competition from lower-cost alternatives
- Vulnerability to exploits used by criminals
Opportunities
- Expansion into new markets (e.g., enterprise security)
- Development of new products and services
- Partnerships with other technology companies
- Increased demand for digital intelligence solutions
- Growth in cloud-based data analysis
Threats
- Increasing competition
- Evolving privacy regulations
- Technological advancements by criminals
- Budget cuts in government spending
- Negative publicity related to ethical concerns
Competitors and Market Share
Key Competitors
- MSAB (MSAB.ST)
- Magnet Forensics (MAGT.TO)
- Grayshift (Private)
Competitive Landscape
Cellebrite DI has a strong competitive position due to its comprehensive platform and established customer base. However, it faces increasing competition from companies offering lower-cost alternatives or specialized solutions.
Major Acquisitions
BlackBag Technologies
- Year: 2020
- Acquisition Price (USD millions): 33
- Strategic Rationale: Acquisition of BlackBag Technologies expanded Cellebrite's capabilities in computer forensics and enhanced its digital intelligence platform.
Growth Trajectory and Initiatives
Historical Growth: unavailable
Future Projections: Analysts project continued growth in the digital intelligence market, driven by the increasing volume of digital evidence. Cellebrite DI is expected to benefit from this trend.
Recent Initiatives: Cellebrite DI has been focused on expanding its cloud-based offerings and developing new analytics capabilities.
Summary
Cellebrite DI is a leading player in the digital intelligence market with a strong brand and advanced technology. Its reliance on government contracts and ethical concerns are risks. Growth is expected as the demand for digital intelligence solutions increases, and expanding into new markets will be vital for long term success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Analyst Reports
- Public Financial Filings (where available)
Disclaimers:
This analysis is based on publicly available information and estimates and should not be considered financial advice. Market share and financial data may not be precise due to limited availability. Investment decisions should be made after consulting with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cellebrite DI
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-08-31 | CEO & Director Mr. Thomas E. Hogan | ||
Sector Technology | Industry Software - Infrastructure | Full time employees 1167 | Website https://www.cellebrite.com |
Full time employees 1167 | Website https://www.cellebrite.com | ||
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Endpoint Mobile Now; and professional services, such as training and certification services, and advanced services. It serves federal and state and local agencies. The company was founded in 1999 and is headquartered in Petah Tikva, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.